NFKB1 and neoplasm: It also significantly inhibited ERK phosphorylation and NF-κB activation after the receptor, and 1,3-diphenylpropenone (10 μg/mL) considerably inhibited tumor growth and tumor-induced angiogenesis, as shown in HT29 cell-inoculated CAM assay.